{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:02:26Z","timestamp":1790226146893,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Immunoglobulin A nephropathy (IgAN) is a heterogeneous disease, and early identification of patients at high risk of rapid renal deterioration remains challenging. In this multicenter retrospective study, 483 patients with biopsy-proven IgAN at chronic kidney disease stages 1\u20133 were enrolled and randomly assigned to a training cohort (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009338) and an internal validation cohort (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009145). Rapid renal function decline was defined as a decline of at least 25% in estimated glomerular filtration rate or progression to ESRD, analyzed as a time-to-event outcome from renal biopsy (the 1-year risk was the principal metric reported). Independent predictors were identified using Cox proportional hazards regression, and a nomogram was developed and internally validated. In the training cohort, 83 patients (24.6%) reached the endpoint during follow-up (median time to event 13.6 months). Multivariable analysis showed that renal tissue Lambda light chain deposition, higher systolic blood pressure, serum chloride, blood urea nitrogen, and Oxford C score were independent risk factors, whereas higher serum complement C3 and potassium were protective factors. The nomogram showed good discrimination, with a 1-year time-dependent area under the receiver operating characteristic curve (AUC) of 0.86 (95% CI: 0.81\u20130.92) in the training cohort and 0.80 (95% CI: 0.69\u20130.91) in the validation cohort. SHAP analysis identified Lambda light chain deposition as the most influential predictor. In conclusion, we developed and internally validated a nomogram integrating clinicopathological variables to predict rapid renal function decline in early-stage IgAN, which may facilitate early risk stratification and individualized management.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1857665","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:34:16Z","timestamp":1790224456000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a predictive model for rapid renal function decline in early IgA nephropathy: a multicenter retrospective study"],"prefix":"10.3389","volume":"13","author":[{"given":"Junan","family":"Zhou","sequence":"first","affiliation":[{"name":"HuZhou Postgraduate Joint Training Base, Zhejiang Chinese Medical University","place":["China"]},{"name":"Huzhou Key Laboratory of Chronic Kidney Disease, First Affiliated Hospital, Huzhou University","place":["Huzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Huzhou University","place":["Huzhou, China"]},{"name":"Huzhou Key Laboratory of Chronic Kidney Disease, First Affiliated Hospital, Huzhou University","place":["Huzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Huo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Huzhou University","place":["Huzhou, China"]},{"name":"Huzhou Key Laboratory of Chronic Kidney Disease, First Affiliated Hospital, Huzhou University","place":["Huzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Huzhou Central Hospital","place":["Huzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhelun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Huzhou University","place":["Huzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Huzhou University","place":["Huzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Huzhou University","place":["Huzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaai","family":"Zhang","sequence":"additional","affiliation":[{"name":"HuZhou Postgraduate Joint Training Base, Zhejiang Chinese Medical University","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Yu","sequence":"additional","affiliation":[{"name":"HuZhou Postgraduate Joint Training Base, Zhejiang Chinese Medical University","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyong","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Huzhou Central Hospital","place":["Huzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Huzhou University","place":["Huzhou, China"]},{"name":"Huzhou Key Laboratory of Chronic Kidney Disease, First Affiliated Hospital, Huzhou University","place":["Huzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"i15","DOI":"10.1093\/ndt\/gfaf135","article-title":"How should we measure and interpret glomerular inflammation and what is the best anti-inflammatory approach in IgA nephropathy?","volume":"41","author":"Yau","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","article-title":"IgA nephropathy","volume":"9","author":"Stamellou","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1681\/ASN.2022020201","article-title":"Further evidence for the mucosal origin of pathogenic IgA in IgA nephropathy","volume":"33","author":"Cheung","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0140-6736(25)01942-7","article-title":"Chronic kidney disease","volume":"407","author":"Herrington","year":"2026","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"151572","DOI":"10.1016\/j.semnephrol.2025.151572","article-title":"Current biomarkers of IgA nephropathy","volume":"44","author":"Kamal","year":"2024","journal-title":"Semin Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.clinthera.2021.03.009","article-title":"Low-dose corticosteroid combined with mycophenolate mofetil for IgA nephropathy with stage 3 or 4 CKD: a retrospective cohort study","volume":"43","author":"Zhao","year":"2021","journal-title":"Clin Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2215\/CJN.05950612","article-title":"Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy","volume":"8","author":"Rocchetti","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ki.2013.317","article-title":"Validation of the 30% reduction in estimated glomerular filtration rate as a surrogate end point for renal replacement therapy in patients with immunoglobulin A nephropathy","volume":"85","author":"Le","year":"2014","journal-title":"Kidney Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12882-024-03545-7","article-title":"Predicting chronic kidney disease progression with artificial intelligence","volume":"25","author":"Isaza-Ruget","year":"2024","journal-title":"BMC Nephrol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1001\/jamainternmed.2019.0600","article-title":"A validated international IgA nephropathy prediction tool","volume":"179","author":"Barbour","year":"2019","journal-title":"JAMA Intern Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.ekir.2022.08.003","article-title":"Clinicopathologic significance of predominant lambda light chain deposition in IgA nephropathy","volume":"7","author":"Ravipati","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3109\/00365599709070350","article-title":"Analysis of charge distribution of lambda- and kappa-IgA in IgA nephropathy by focused antigen capture immunoassay","volume":"31","author":"Suen","year":"1997","journal-title":"Scand J Urol Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2512393","DOI":"10.1080\/0886022X.2025.2512393","article-title":"Characteristics of adult membranous nephropathy patients with capillary co-deposition of IgG and IgA","volume":"47","author":"Guan","year":"2025","journal-title":"Ren Fail"},{"key":"B14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.25259\/ijn_489_23","article-title":"Hemato-Renal profile of proliferative glomerulonephritis with monoclonal immunoglobulin deposits","volume":"35","author":"Johny","year":"2024","journal-title":"Indian J Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/diagnostics11030420","article-title":"Randall-Type monoclonal immunoglobulin deposition disease: new insights into the pathogenesis, diagnosis and management","volume":"11","author":"Cohen","year":"2021","journal-title":"Diagnostics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e232194","DOI":"10.1371\/journal.pone.0232194","article-title":"A cross-sectional analysis of clinicopathologic similarities and differences between henoch-sch\u00f6nlein purpura nephritis and IgA nephropathy","volume":"15","author":"Sugiyama","year":"2020","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ki.2015.252","article-title":"New developments in the genetics, pathogenesis, and therapy of IgA nephropathy","volume":"88","author":"Magistroni","year":"2015","journal-title":"Kidney Int"},{"key":"B18","doi-asserted-by":"publisher","first-page":"30795","DOI":"10.1038\/s41598-025-16380-z","article-title":"Exploring the molecular mechanism of budesonide enteric capsules in the treatment of IgA nephropathy based on bioinformatics","volume":"15","author":"Lin","year":"2025","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.ekir.2022.01.1053","article-title":"Clinicopathologic and prognostic study of primary IgA nephropathy with light chain \u03bb restriction in the mesangial deposits","volume":"7","author":"Zhang","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ekir.2018.07.021","article-title":"Clinical characteristics and treatment patterns of children and adults with IgA nephropathy or IgA vasculitis: findings from the CureGN study","volume":"3","author":"Selewski","year":"2018","journal-title":"Kidney Int Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/jcm13010123","article-title":"An update on the genetics of IgA nephropathy","volume":"13","author":"Xu","year":"2023","journal-title":"J Clin Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3390\/life15101497","article-title":"Biomarkers in lupus nephritis: an evidence-based comprehensive review","volume":"15","author":"Vrabie","year":"2025","journal-title":"Life (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e40495","DOI":"10.1371\/journal.pone.0040495","article-title":"Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"16224","DOI":"10.1038\/s41598-024-65857-w","article-title":"Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy","volume":"14","author":"Tringali","year":"2024","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12882-025-04253-6","article-title":"Classification of primary glomerulonephritis using machine learning models: a focus on IgA nephropathy prediction","volume":"26","author":"Hu","year":"2025","journal-title":"BMC Nephrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/imcb.12324","article-title":"Antibody-mediated complement activation in pathology and protection","volume":"98","author":"Goldberg","year":"2020","journal-title":"Immunol Cell Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1681\/ASN.2005090923","article-title":"Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease","volume":"17","author":"Roos","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3389\/fimmu.2012.00341","article-title":"Which pathways trigger the role of complement in ischaemia\/reperfusion injury?","volume":"3","author":"Farrar","year":"2012","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"103835","DOI":"10.1016\/j.autrev.2025.103835","article-title":"New thoughts on the intestinal microbiome-B cell-IgA axis and therapies in IgA nephropathy","volume":"24","author":"Dang","year":"2025","journal-title":"Autoimmun Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e70382","DOI":"10.1002\/mco2.70382","article-title":"Immunoglobulin a nephropathy: molecular pathogenesis and targeted therapy","volume":"6","author":"Zhou","year":"2025","journal-title":"MedComm"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2577164","DOI":"10.1080\/0886022X.2025.2577164","article-title":"BAFF in autoimmune kidney diseases: pathogenic pathways, biomarker potential, and therapeutic horizons","volume":"47","author":"Wu","year":"2025","journal-title":"Ren Fail"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1035147039","DOI":"10.1177\/20543581231191839","article-title":"Knowledge translation in glomerulonephritis: successes in translational research from the bench to bedside","volume":"10","author":"Yau","year":"2023","journal-title":"Can J Kidney Health Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/ndt\/gfy302","article-title":"Is there long-term value of pathology scoring in immunoglobulin a nephropathy? A validation study of the Oxford classification for IgA nephropathy (VALIGA) update","volume":"35","author":"Coppo","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/jcm12237361","article-title":"Colocalization of IgG and IgA heavy chains with kappa and lambda light chains in glomerular deposits of IgA nephropathy patients using high-resolution confocal microscopy and correlation with Oxford MEST-C scores","volume":"12","author":"Rizk","year":"2023","journal-title":"J Clin Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1093\/ndt\/gfaf084","article-title":"CKD progression, kidney failure, and mortality among US patients with IgA nephropathy","volume":"40","author":"Sim","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/ndt\/gfae252","article-title":"Long-term outcomes of IgA nephropathy in China","volume":"40","author":"Shen","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1093\/ndt\/gfad125","article-title":"Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy","volume":"38","author":"Peters","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/ndt\/gfae263","article-title":"The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial","volume":"40","author":"Judge","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1097\/CM9.0000000000003754","article-title":"Causal role of circulating inflammatory cytokines in the pathogenesis of IgA nephropathy","volume":"138","author":"Han","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"645","DOI":"10.34067\/KID.0000000735","article-title":"Intensity of glomerular C3 deposits in IgA nephropathy predicts early KRT","volume":"6","author":"Venda","year":"2025","journal-title":"Kidney360"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4132\/jptm.2025.09.17","article-title":"Significance of KM55 immunohistochemical staining in the diagnosis and prognosis of IgA nephropathy","volume":"60","author":"Jeong","year":"2026","journal-title":"J Pathol Transl Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1681\/ASN.2021081086","article-title":"Galactose-deficient IgA1 B cells in the circulation of IgA nephropathy patients carry preferentially lambda light chains and mucosal homing receptors","volume":"33","author":"Zachova","year":"2022","journal-title":"J Am Soc Nephrol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1857665\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:34:33Z","timestamp":1790224473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1857665\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":43,"alternative-id":["10.3389\/fmed.2026.1857665"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1857665","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1857665"}}